Six months after the Granuflo recall, a wrongful death lawsuit was filed on behalf of a man who died from a heart attack after being treated with GranuFlo. A more recent lawsuit filed in January 2014 by the family of a woman who died of cardiac arrest alleges that GranuFlo and NaturaLyte were associated with a risk of metabolic alkalosis, but failed to provide adequate warnings regarding this danger. And that has Larry wondering if his mother’s death was caused by Granuflo.
“My mother always had her dialysis treatment at McLaren Hospital but she had an appointment at Hurley Hospital for an unrelated reason and decided to schedule her dialysis at their dialysis clinic,” says Larry. “Mom passed away as she was being wheeled out of the dialysis clinic to her next appointment. The transportation aid who was assisting her told me that she ‘died in mid sentence.’ My family and I can’t help but wonder if her death was caused by the dosage of GranuFlo she received during dialysis.”
Larry also found out, after a quick online search, that McLaren’s dialysis clinic did not use GranuFlo in its dialysis procedure but Hurley’s Medical Center Dialysis Unit does. Of course he also can’t help but think his mother might be alive today had she stayed with McLaren’s dialysis clinic.
READ MORE GRANUFLO RECALL LEGAL NEWS
In November 2011, Fresenius Medical Care told doctors working in its clinics about the increased risk of heart attacks and strokes that its Naturalyte Liquid Acid and Granuflo products could potentially cause for patients who already have high bicarbonate levels. It wasn’t until March 2012 that Fresenius shared such information with other dialysis centers - after the FDA issued a recall (March 29, 2012) of its dialysis products.
Fresenius is one of the largest dialysis product manufacturers in the world. It operates dozens of dialysis centers in the US, which provides dialysis for more than 100,000 people.